Microdrilling Surgery for Full Thickness Chondral Lesions of the Knee Augmented With Concentrated Bone Marrow Aspirate, Platelet Rich Plasma and Hyaluronic Acid
Primary Purpose
Unilateral Primary Osteoarthritis of Knee, Osteoarthritis Knee, Degeneration; Articular Cartilage, Knee
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Microdrilling Surgery
Injections of BMAC + PRP + HA
Sponsored by

About this trial
This is an interventional treatment trial for Unilateral Primary Osteoarthritis of Knee
Eligibility Criteria
Inclusion Criteria: MRI-confirmed full-thickness unipolar or bipolar chondral lesion(s) from osteoarthritis.
Exclusion Criteria:
- Inflammatory arthritis
- Body mass index (BMI) greater than 35
- Presence of significant varus or valgus knee instability or unusually stiff knee
- Greater than 50% deviation of the mechanical axis
- Presence of active cardiac disease
- Presence of active pulmonary disease
- Prior septic arthritis of the involved joint
- Presence of active bacterial or Mycobacterial infection
- Presence of a known hypercoagulable state
- Pregnant or lactating females
- Subject known to be positive for hepatitis B, hepatitis C, or HIV
- Known allergy to hyaluronic acid
- Patients who are unable or unwilling to participate fully in post-operative physical therapy
- Patients with a contraindication to MRI scanning
- Any disorder that compromises ability to give consent or comply with study procedures
- Patients who are felt to be at significantly increased risk for elective orthopedic surgery
- Non-ambulatory patients
- Patients with cognitive impairment
Sites / Locations
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Augmented Microdrilling Surgery
Arm Description
Outcomes
Primary Outcome Measures
Change in International Knee Documentation Committee (IKDC) score
Secondary Outcome Measures
Joint Space Changes
Evaluated by plain radiographs
MRI appearance of repair cartilage
Evaluated using the MOCART scoring system
Frequency of adverse events requiring additional procedures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT02285725
Brief Title
Microdrilling Surgery for Full Thickness Chondral Lesions of the Knee Augmented With Concentrated Bone Marrow Aspirate, Platelet Rich Plasma and Hyaluronic Acid
Study Type
Interventional
2. Study Status
Record Verification Date
July 2023
Overall Recruitment Status
Completed
Study Start Date
March 2011 (Actual)
Primary Completion Date
February 15, 2019 (Actual)
Study Completion Date
February 15, 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Joseph E. Broyles
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
This study seeks to evaluate a treatment for multiple full thickness chondral lesions in the knee. Eligible subjects will undergo a microdrilling surgery and up to 12 post operative intra-articular injections of bone marrow aspirate concentrate (BMAC), platelet rich plasma (PRP) and hyaluronic acid (HA).
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Unilateral Primary Osteoarthritis of Knee, Osteoarthritis Knee, Degeneration; Articular Cartilage, Knee, Degenerative Lesion of Articular Cartilage of Knee
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
21 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Augmented Microdrilling Surgery
Arm Type
Experimental
Intervention Type
Procedure
Intervention Name(s)
Microdrilling Surgery
Intervention Description
All patients will undergo an arthroscopic surgical procedure in which small holes are drilled throughout the areas of damaged cartilage (standard of care)
Intervention Type
Procedure
Intervention Name(s)
Injections of BMAC + PRP + HA
Intervention Description
All patients will receive up to 12 intra-articular knee injections of BMAC (derived from iliac crest), PRP (derived from peripheral blood) and HA
Primary Outcome Measure Information:
Title
Change in International Knee Documentation Committee (IKDC) score
Time Frame
Change from baseline at 5 years post-operatively
Secondary Outcome Measure Information:
Title
Joint Space Changes
Description
Evaluated by plain radiographs
Time Frame
2 and 5 years post-operatively
Title
MRI appearance of repair cartilage
Description
Evaluated using the MOCART scoring system
Time Frame
2 and 5 years post-operatively
Title
Frequency of adverse events requiring additional procedures
Time Frame
Continuously for 5 years post-operatively
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
64 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: MRI-confirmed full-thickness unipolar or bipolar chondral lesion(s) from osteoarthritis.
Exclusion Criteria:
Inflammatory arthritis
Body mass index (BMI) greater than 35
Presence of significant varus or valgus knee instability or unusually stiff knee
Greater than 50% deviation of the mechanical axis
Presence of active cardiac disease
Presence of active pulmonary disease
Prior septic arthritis of the involved joint
Presence of active bacterial or Mycobacterial infection
Presence of a known hypercoagulable state
Pregnant or lactating females
Subject known to be positive for hepatitis B, hepatitis C, or HIV
Known allergy to hyaluronic acid
Patients who are unable or unwilling to participate fully in post-operative physical therapy
Patients with a contraindication to MRI scanning
Any disorder that compromises ability to give consent or comply with study procedures
Patients who are felt to be at significantly increased risk for elective orthopedic surgery
Non-ambulatory patients
Patients with cognitive impairment
12. IPD Sharing Statement
Links:
URL
http://cartilageregenerationcenter.com
Description
Related Info
Learn more about this trial
Microdrilling Surgery for Full Thickness Chondral Lesions of the Knee Augmented With Concentrated Bone Marrow Aspirate, Platelet Rich Plasma and Hyaluronic Acid
We'll reach out to this number within 24 hrs